Profound Medical Corp. (PROF)
NASDAQ: PROF · Real-Time Price · USD
7.69
-0.14 (-1.79%)
Nov 20, 2024, 4:00 PM EST - Market closed
Profound Medical Market Cap
Profound Medical has a market cap or net worth of $188.42 million as of November 21, 2024. Its market cap has decreased by -4.11% in one year.
Market Cap
188.42M
Enterprise Value
168.27M
1-Year Change
-4.11%
Ranking
Category
Stock Price
$7.69
Market Cap Chart
Since October 30, 2019, Profound Medical's market cap has increased from $113.60M to $188.42M, an increase of 65.87%. That is a compound annual growth rate of 10.51%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2024 | 189.60M | 4.52% |
| Dec 29, 2023 | 181.40M | -20.19% |
| Dec 30, 2022 | 227.30M | -2.53% |
| Dec 31, 2021 | 233.20M | -42.21% |
| Dec 31, 2020 | 403.50M | 210.86% |
| Dec 31, 2019 | 129.80M | 14.26% |
View and export this data all the way back to 2019.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lexeo Therapeutics | 199.06M |
| Acrivon Therapeutics | 198.65M |
| Orchestra BioMed Holdings | 196.53M |
| Compass Therapeutics | 195.38M |
| InfuSystem Holdings | 193.50M |
| Sight Sciences | 191.34M |
| Nektar Therapeutics | 189.99M |
| Jin Medical International | 189.42M |